The Economy of healthcare congress
During the period of 10th – 13th June 2011, the world congress on the Economy of healthcare held in Toronto will publish a study in the field of modern therapy comparing the treatment of damaged knee cartilage by the newest method of implanting one’s own cultivated cartilage cells to the current surgical orthopedic treatment. The comparison will include an economical evaluation of medical expenses for individual treatments. The results of the study show that the modern method of implanting one's own cultivated cartilage cells seems to be more economical than conventional treatment.
This modern treatment is available in the Czech Republic via the Chondrograft 1000 and Chondrograft 2000 preparations.
Innovations in transplantology save patients
The first and second complete facial transplant has been performed by MUDr. Bohdanem Pomahačem, the head of the Plastic Surgery Clinic at the Brigham and Women's Hospital in Boston (www.brighamandwomens.org). The surgery has shown that conventional transplantology is still a highly innovational field of medicine. This can also be seen in the first successful sternum reconstruction from bone allotransplants performed last year in University Hospital Olomouc in cooperation with the tissue institution at University Hospital Brno.
Installation of unique technologies
An isolator line and large-capacity clean areas were installed as part of the new center for development and production of modern therapy products. The technology will be used for the production of implants from one’s own as well as allogeneic cells of patients.
3rd nationwide conference BIOIMPLANTOLOGY 2011
University Hospital Brno, National Tissue Center a.s. and the Society for Bioimplantology ČLS JEP, represented by MUDr. Roman Kraus, MBA, UHB director and MUDr. Pavel Březovský, CSc., MBA, director of the Transplantation Coordination Center, have held the 3rd nationwide conference called BIOIMPLANTOLOGY 2011.
A unique center for high-quality medicine is being built in Ostrava
Representatives of PrimeCell, a.s., National Tissue Center, a.s., and University Hospital Ostrava have successfully passed consultation in the National Institute for Drug Control regarding the new scientific-technical park called 4 MEDI in Ostrava. The center will be designated for high-capacity production of high-quality products for modern therapy and cell transplants.
NTC bio medical center
PrimeCell is preparing for the commencement of operation of the bio medical center in Campus Science and Business park in Brno, at Palach square in Bohunice. The grand opening will occur between 28th – 30th June.
The senate has approved new rules for modern therapy
The senate has approved the appropriate novelization of the law on drugs in May, fulfilling EU directives regarding the ensuring of quality, efficiency and safety of preparations for modern therapy; i.e. medical preparations for genetic and somato-cellular therapy and preparations of tissue engineering.
Top-notch results of Czech research and medicine
National Tissue Center, a.s., was the co-host of the „Bioimplantologie 2011“ conference. The event had high participation and introduced the newest results of Czech and Slovak doctors and researchers in the field of modern therapy, biotechnology and material engineering.
Hope for Patients
A significant event in the biotechnology field, the Bio Europe Spring 2011 conference held this year in Milan, opened new pathways for mutual business cooperation and developing the field. PrimeCell made a number of valuable agreements in the area of stem cell treatments, supporting our goal of making treatment available to a broader group of patients in the future.
New Research Partner
PrimeCell has expanded its innovation and development partner network to include the Faculty of Biomedical Engineering at Czech Technical University in Prague and a team headed by Prof. Miroslav Jelínek, DrSc. Cooperation will continue in layering tissue carriers for tissue engineering applications. The research partner network takes in more than 50 public institutions, universities and private firms in all.
We fulfil the visions of modern medicine
In implementing projects, the Primecell Group provides important support for investment in science and research in the Czech Republic. This year, PrimeCell R&D Group development and investment projects accounted for an astounding volume of more than €40 million.